← Back
Data updated: Jun 28, 2026
CEE KAY SUPPLY
Pharma Pharmaceuticals
CEE KAY SUPPLY is a pharmaceutical company with 1 FDA-approved products.
2014
Since
1
Drugs
-
Trials
2
New Drugs (2yr)
Modality:
1 Small Molecules
CEE KAY SUPPLY's Key Drugs
CEE KAY SUPPLY's core commercial portfolio centers on MEDICAL AIR, USP — its most strategically important drugs approved in the last 15 years.
CEE KAY SUPPLY's Recent FDA Approvals
CEE KAY SUPPLY secured 2 new FDA approvals for novel drugs (NDA/BLA) in the last two years.
CEE KAY SUPPLY's Therapeutic Areas
Disease areas where CEE KAY SUPPLY has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CEE KAY SUPPLY Pipeline Snapshot
Active clinical trials for CEE KAY SUPPLY across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • MEDICAL AIR, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2014-04-22
- Latest
- 2014-04-22
- Applications
- 1